Vancouver, BC, August 27, 2019--Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, reported financial results for its second quarter ended June 30, 2019 and commented on recent accomplishments and plans.
|